Nextage Therapeutics (XTAE:NXTG) Short-Term Capital Lease Obligation : ₪0.08 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Short-Term Capital Lease Obligation?

Nextage Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪0.08 Mil.

Nextage Therapeutics's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (₪0.00 Mil) to Jun. 2023 (₪0.11 Mil) but then declined from Jun. 2023 (₪0.11 Mil) to Dec. 2023 (₪0.08 Mil).

Nextage Therapeutics's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₪0.03 Mil) to Dec. 2022 (₪0.00 Mil) but then increased from Dec. 2022 (₪0.00 Mil) to Dec. 2023 (₪0.08 Mil).

Nextage Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Nextage Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Short-Term Capital Lease Obligation Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.07

0.03

0.08

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial									0.03	0.01	-	0.11	0.08

Nextage Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Nextage Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021